{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:26:06Z","timestamp":1794061566188,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY16H280013"],"award-info":[{"award-number":["LY16H280013"]}]},{"name":"Innovation and Entrepreneurship Training Program of Zhejiang University of Technology","award":["2017106"],"award-info":[{"award-number":["2017106"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biopha.2018.06.055","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T13:08:16Z","timestamp":1529413696000},"page":"915-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats"],"prefix":"10.1016","volume":"105","author":[{"given":"Hui-lin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-guo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-you","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.06.055_bib0005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijpharm.2017.06.070","article-title":"Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy","volume":"528","author":"Yue","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2018.06.055_bib0010","article-title":"Mapping txnip: key connexions in progression of diabetic nephropathy","author":"Kumar","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.055_bib0015","first-page":"48","article-title":"Modelling diabetic nephropathy in mice, nature reviews","volume":"14","author":"Azushima","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.biopha.2018.06.055_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.freeradbiomed.2017.12.040","article-title":"Diabetic nephropathy: Is there a role for oxidative stress?","volume":"116","author":"Sagoo","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2018.06.055_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jnutbio.2017.11.008","article-title":"Zinc supplementation alleviates the progression of diabetic nephropathy by inhibiting the overexpression of oxidative-stress-mediated molecular markers in streptozotocin-induced experimental rats","volume":"54","author":"Barman","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2018.06.055_bib0030","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cyto.2013.01.008","article-title":"Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-kappaB-mediated inflammatory genes expression","volume":"61","author":"Gui","year":"2013","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.biopha.2018.06.055_bib0035","doi-asserted-by":"crossref","first-page":"e0163208","DOI":"10.1371\/journal.pone.0163208","article-title":"Influence of different levels of lipoic acid synthase gene expression on diabetic nephropathy","volume":"11","author":"Xu","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.06.055_bib0040","first-page":"948417","article-title":"Inflammatory cytokines in diabetic nephropathy","author":"Donate-Correa","year":"2015","journal-title":"J. Diabetes Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.06.055_bib0045","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1159\/000356619","article-title":"AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-kappaB pathway in rat mesangial cells: inhibition by sesquiterpene lactones","volume":"32","author":"Wang","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2018.06.055_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4239\/wjd.v5.i4.431","article-title":"Inflammation in diabetic kidney disease","volume":"5","author":"Garcia-Garcia","year":"2014","journal-title":"World J. Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2018.06.055_bib0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.2015.250","article-title":"Relevance of TNF-\u03b1 in the context of other inflammatory cytokines in the progression of diabetic nephropathy","volume":"88","author":"Sun","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.06.055_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.foodres.2017.10.028","article-title":"Recent developments on the extraction and application of ursolic acid. A review","volume":"103","author":"L\u00f3pez-Hortas","year":"2018","journal-title":"Food Res. Int."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.055_bib0065","doi-asserted-by":"crossref","first-page":"e0117400","DOI":"10.1371\/journal.pone.0117400","article-title":"Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21\/PTEN\/Akt\/mTOR suppression","volume":"10","author":"Lu","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.06.055_bib0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lfs.2016.01.017","article-title":"Ursolic acid (UA): a metabolite with promising therapeutic potential","volume":"146","author":"Kashyap","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.06.055_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.curtheres.2013.07.001","article-title":"Ursolic acid provides kidney protection in diabetic rats","volume":"75","author":"Chen","year":"2013","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"4","key":"10.1016\/j.biopha.2018.06.055_bib0080","first-page":"565","article-title":"Ursolic acid inhibits early lesions of diabetic nephropathy","volume":"26","author":"Zhou","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2018.06.055_bib0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc06-1998","article-title":"Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes","volume":"30","author":"Makino","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2018.06.055_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/157339912800563972","article-title":"Telmisartan in the management of diabetic nephropathy: a contemporary View","volume":"8","author":"Balakumar","year":"2007","journal-title":"Curr. Diabetes Rev."},{"issue":"5","key":"10.1016\/j.biopha.2018.06.055_bib0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s12272-012-0513-0","article-title":"Attenuation of aortic injury by ursolic acid through RAGE-Nox-NFkappaB pathway in streptozocin-induced diabetic rats","volume":"35","author":"Xiang","year":"2012","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.biopha.2018.06.055_bib0100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.biopha.2017.11.032","article-title":"Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats","volume":"97","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.06.055_bib0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2016.08.022","article-title":"Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update","volume":"791","author":"Bhattacharjee","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.055_bib0110","article-title":"Extracellular superoxide dismutase attenuates renal oxidative stress through the activation of adenosine monophosphate-activated protein kinase in diabetic nephropathy","author":"Hong","year":"2017","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.biopha.2018.06.055_bib0115","first-page":"232404","article-title":"Relationship between Oxidant\/Antioxidant markers and severity of microalbuminuria in the early stage of nephropathy in type 2 diabetic patients","author":"Shao","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2018.06.055_bib0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijbiomac.2018.01.009","article-title":"Antioxidation, anti-hyperglycaemia and renoprotective effects of extracellular polysaccharides from Pleurotus eryngii SI-04","volume":"111","author":"Zhang","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2018.06.055_bib0125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.carbpol.2016.03.071","article-title":"Antioxidative and renoprotective effects of residue polysaccharides from Flammulina velutipes","volume":"146","author":"Lin","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2018.06.055_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2018.01.010","article-title":"Gallic acid attenuates type I diabetic nephropathy in rats","volume":"282","author":"Garud","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.biopha.2018.06.055_bib0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jfda.2016.03.009","article-title":"Myrciaria cauliflora extract improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-nicotinamide mice","volume":"24","author":"Hsu","year":"2016","journal-title":"J. Food Drug. Anal."},{"issue":"8","key":"10.1016\/j.biopha.2018.06.055_bib0140","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00125-016-4030-4","article-title":"Novel anti-inflammatory drugs for the treatment of diabetic kidney disease","volume":"59","author":"Heerspink","year":"2016","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2018.06.055_bib0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s12020-014-0437-1","article-title":"Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment","volume":"48","author":"Barutta","year":"2014","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.biopha.2018.06.055_bib0150","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ki.2013.215","article-title":"Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism","volume":"84","author":"You","year":"2013","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.biopha.2018.06.055_bib0155","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2018.06.055_bib0160","doi-asserted-by":"crossref","first-page":"e99633","DOI":"10.1371\/journal.pone.0099633","article-title":"Nuclear NF-\u03baB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy","volume":"9","author":"Alvarez","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.biopha.2018.06.055_bib0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/dna.2013.2204","article-title":"Association between the interleukin-1beta Gene (IL1B) C-511T polymorphism and the risk of diabetic nephropathy in type 2 diabetes: a candidate-gene association study","volume":"33","author":"Stefanidis","year":"2014","journal-title":"DNA Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.055_bib0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcp.25429","article-title":"anti-diabetic agent sodium tungstate induces the secretion of pro- and anti-inflammatory cytokines by human kidney cells","volume":"232","author":"Bertinat","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2018.06.055_bib0175","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/13543784.2016.1196184","article-title":"Targeting inflammation in diabetic kidney disease: early clinical trials","volume":"25","author":"Perez-Gomez","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.biopha.2018.06.055_bib0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajpath.2014.09.021","article-title":"Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor \u03b1 and IL-1\u03b2 in nucleus pulposus cells","volume":"185","author":"Ye","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2018.06.055_bib0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2012.11.033","article-title":"Ursolic acid, a potential PPARgamma agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma","volume":"701","author":"Kim","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2018.06.055_bib0190","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700332","article-title":"Ursolic acid, a natural nutraceutical agent, targets Caspase3 and alleviates inflammation-associated downstream Signal transduction","volume":"61","author":"Ma","year":"2017","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218313817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218313817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:39:50Z","timestamp":1731447590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218313817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"alternative-id":["S0753332218313817"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.055","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}